Photo via Fox News

New belly fat injection cuts dangerous fat surrounding organs by 12% in early human trial

Read the original at Fox News ↗
Cite

Chafe, S. (2026, October 11). New belly fat injection cuts dangerous fat surrounding organs by 12% in early human trial. Fox News. https://www.foxnews.com/health/belly-fat-injection-cuts-dangerous-fat-surrounding-organs-12-percent-early-human-trial

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Fox News · collected 2026-10-11 · by Sadie Chafe

Quick Summary

Early human trials of an experimental injection called CBL-514 have shown promise in reducing dangerous visceral fat by 12% on average after four weeks. Conducted by researchers at the University of Alabama at Birmingham and Caliway Biopharmaceuticals, the study involved participants receiving injections every three weeks for up to 12 weeks, with doses ranging up to 600 milligrams based on abdominal fat thickness. MRI scans revealed that visceral fat decreased in those who received CBL-514 while increasing in a placebo group. The injection works by selectively causing apoptosis—cell self-destruction—in fat cells without harming surrounding tissues.
Written by AI on 2026-10-11, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Early human trials of an experimental injection called CBL-514 have shown promise in reducing dangerous visceral fat deposits. Conducted by Dr. W. Timothy Garvey from the University of Alabama at Birmingham and Yu-Fang Ling from Caliway Biopharmaceuticals in New Taipei City, Taiwan, these studies involved administering 600 milligrams of CBL-514 to participants every three weeks for up to 12 weeks via injections into their lower abdomen. MRI scans revealed that those receiving the injection experienced a 12% reduction in visceral fat compared to an increase among those given a placebo. This development is significant as visceral fat, located deep inside the abdomen around internal organs, impacts metabolism and can contribute to insulin resistance and type 2 diabetes. The research also aligns with previous findings by the American Heart Association that indicated visceral fat has a stronger association with heart failure risk than BMI.

Written for “Belly Fat Injection Trial” on 2026-11-03, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Belly Fat Injection Trial
Health · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
14
sentences that state something as happening or true
Uncertain
14%
2 of 14 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
69/100
Fox News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-11 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Fox News · 6337 article(s) · 11 correction(s) detected
Running correction rate · 11 correction(s)

Who wrote this

Sadie Chafe
23 article(s) here · 1 carrying a prediction
🔮 Cortisol naturally peaks in the morning, according to the Cleveland Clinic, so the "spike" in cortisol some people attribute to drinking coffee on an empty stomach might just be a natural process rather than a side effect of the coffee.
🔮 In order to avoid large crowds and a chaotic shopping experience, customers might want to stay away from Costco on certain afternoons.
🔮 "For me personally, the best breakfast sandwich is the McDonald's Sausage Biscuit, then after that would be the Chic-fil-A Chicken Biscuit!" said another person.
🔮 In-N-Out Burger CEO Lynsi Snyder has hinted at future expansions for the California-based fast-food chain, mentioning Arkansas, Mississippi and Oklahoma as three states that might welcome In-N-Out restaurants in the years to come.
🔮 The proper special authorities, which in this case include The Lower Nature Conservation Authority and the Veterinary and Food Surveillance Office, will be given a police report and determine next steps, according to the news release. "The Veterinary and Food Surveillance Office will visit the wildlife park promptly and carry out an on-site animal welfare control," the release noted.
🔮 "It's the only other candy I would hope for aside from Reese's pieces if I was trick-or-treating," a candy corn fan said on Reddit.
🔮 The report showed that women have just under 50% more neurons than men in olfactory regions, a difference that could contribute to a stronger sense of smell.
🔮 Southwest Airlines will add 11 new nonstop international routes to its schedule beginning in November, giving travelers more options for their next tropical escape.
🔮 Another commenter shared a similar sentiment, saying: "Need to serve a churro with it." After roughly two years without its Twisted Churros, Costco announced in September that the cinnamon and sugar-dusted doughy treat would return for a limited time.
🔮 "Our findings suggest that the link between diet and brain health may be detectable before people experience noticeable problems with memory or thinking," said Sonia Anand, senior author of the study and senior scientist at PHRI.
Also by Sadie Chafe
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 23 articles by Sadie Chafe →

Topics

Caliway Biopharmaceuticals New Taipei City Taiwan the American Heart Association the University of Alabama at Birmingham

Subjects

Caliway Biopharmaceuticals ORG · 1× Garvey PERSON · 1× New Taipei City GPE · 1× SciTechDaily ORG · 1× Taiwan GPE · 1× W. Timothy Garvey PERSON · 1× Yu-Fang Ling PERSON · 1× the American Heart Association ORG · 1× the University of Alabama at Birmingham ORG · 1×

Narrative

However, what’s even more important, he noted, is the decrease in body weight, improved blood pressure and cholesterol, and the loss of visceral fat that the injection can cause, as these factors impact overall health.
framing: assertive · carried by 1 article(s) · first seen 2026-10-11
🔮 The trials tested whether the injection could diminish visceral fat deposits, and they were conducted by Dr. W. Timothy Garvey of the University of Alabama at Birmingham and Yu-Fang Ling of Caliway Biopharmaceuticals in New Taipei City, Taiwan.

Claims (14 extracted, 2 hedged)

Early human trials of an experimental injection called CBL-514 have shown potential for reducing deadly visceral fat. asserted
trials → call → fat
Visceral fat, which sits deep inside the abdomen wrapped around internal organs, affects metabolism, influences insulin resistance and can impact the development of type 2 diabetes. asserted
which → sit → diabetes
Research published in March by the American Heart Association found that visceral fat had a stronger association with the risk of heart failure than body mass index (BMI). asserted
fat → publish → index
The trials tested whether the injection could diminish visceral fat deposits, and they were conducted by Dr. W. Timothy Garvey of the University of Alabama at Birmingham and Yu-Fang Ling of Caliway Biopharmaceuticals in New Taipei City, Taiwan. uncertain
they → test → City
Previous phase 2 trials had already shown that the drug could reduce subcutaneous fat, the layer of fat directly beneath the skin. uncertain
drug → show → skin
MRI scans from two phase 2 trials exhibited a decrease in visceral fat in participants who received the CBL-514 drug, while the visceral fat increased in those who received a placebo drug. asserted
who → exhibit → drug
Participants who were given CBL-514 received injections into their lower abdomen every three weeks for up to 12 weeks, with doses of up to 600 milligrams. asserted
who → give → milligrams
The number of injections given to participants depended on the thickness of their abdominal fat. asserted
number → give → fat
As the fat layer decreased in volume, the number of injections also decreased. asserted
number → decrease → injections
The CBL-514 injection selectively sparks apoptosis—a process which causes cells to self-destruct—but only in fat cells, leaving nearby cells unharmed. asserted
cells → spark → cells
Four weeks after the final treatment, the average volume of fat had lowered by 12.01% in the group given CBL-514, while it had increased by 5.68% in the group that received a placebo, SciTechDaily reported. asserted
SciTechDaily → lower → placebo
The potential cosmetic effects, such as a flatter stomach due to subcutaneous fat loss, are appealing to patients, Garvey acknowledged. asserted
Garvey → appeal → patients
However, what’s even more important, he noted, is the decrease in body weight, improved blood pressure and cholesterol, and the loss of visceral fat that the injection can cause, as these factors impact overall health. asserted
factors → ’ → health
Liposuction, a common surgical cosmetic procedure, cannot remove visceral fat, and thus cannot reduce the health risks caused by a high amount of visceral fat. asserted
Liposuction → remove → fat
💬Give feedback
🕘History 🎫Support